DOCSLIB.ORG

Arhgef1 Plays a Vital Role in Platelet Function and Thrombogenesis Hanan Qasim, BS;* Zubair A

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Arhgef1 Plays a Vital Role in Platelet Function and Thrombogenesis Hanan Qasim, BS;* Zubair A ORIGINAL RESEARCH Arhgef1 Plays a Vital Role in Platelet Function and Thrombogenesis Hanan Qasim, BS;* Zubair A. Karim, PhD;* Keziah R. Hernandez, MPA; Dante Lozano; Fadi T. Khasawneh, PhD; Fatima Z. Alshbool, PharmD, PhD Background-—Platelets are the cellular mediators of hemostasis and thrombosis, and their function is regulated by a number of molecular mediators, such as small GTPases. These small GTPases are themselves regulated by guanine nucleotide exchange factors such as Arhgefs, several of which are found in platelets, including the highly expressed Arhgef1. However, the role of Arhgef1 in platelets has not yet been investigated. Methods and Results-—We employed mice with genetic deletion of Arhgef1 (ie, Arhgef1À/À) and investigated their platelet phenotype by employing a host of in vivo and in vitro platelet assays. Our results indicate that Arhgef1À/À mice had prolonged carotid artery occlusion and tail bleeding times. Moreover, platelets from these mice exhibited defective aggregation, dense and a granule secretion, aIIbb3 integrin activation, clot retraction and spreading, in comparison to their wild-type littermates. Finally, we also found that the mechanism by which Arhgef1 regulates platelets is mediated in part by a defect in the activation of the RhoA– Rho-associated kinase axis, but not Rap1b. Conclusions-—Our data demonstrate, for the first time, that Arhgef1 plays a critical role in platelet function, in vitro and in vivo. ( J Am Heart Assoc. 2019;8:e011712. DOI: 10.1161/JAHA.118.011712.) Key Words: Arhgef1 • cardiovascular diseases • platelets • small GTPases • thrombosis latelets are the cellular mediators of hemostasis and nucleotide–binding proteins. These proteins work as P thrombosis.1–3 Under normal conditions and upon injury intracellular “on-off” signaling switches; coordinating signal to a blood vessel, platelets undergo drastic shape change, transduction and amplification.17,18 Several subfamilies of bind to adhesive protein substrates, and aggregate to form a small GTPases have been identified in platelets19,20 and are plug, ultimately halting bleeding.3–5 Unfortunately, hyperac- cardinal regulators of the actin cytoskeleton dynamics, tivity of platelets serves as a precursor to thrombotic diseases affecting platelet aggregation, secretion, spreading, and such as pulmonary embolism and myocardial infarction.6,7 thrombus formation.4,21 They govern the diverse cellular Platelet activation is regulated by a host of complex processes through cycling between an inactive GDP-bound molecular events that modulate adhesion, aggregation, and formandanactiveGTP-boundformthroughaprocessof thrombus formation, and include phosphorylation,8–10 as well GDP/GTP replacement.22,23 Importantly, the GDP/GTP as calcium-based11 and lipid-based signals.12,13 These events cycling is highly regulated by a group of proteins/protein are coordinated by a number of molecular mediators such domains known as guanine nucleotide exchange factors as small GTPases,14–16 which represent a family of (GEFs) such as Arhgefs.23–25 low-molecular-weight (21–25 kDa) monomeric guanine While the Rho family of GEFs––a few of which have been identified in platelets26––has been thoroughly studied in other cell systems,27–29 their role in platelets has not yet been fully From the Department of Pharmaceutical Sciences, School of Pharmacy, The understood. To this end, it has been reported that: (1) Arhgef3 University of Texas El Paso, El Paso, TX (H.Q., Z.A.K., K.R.H., F.T.K., F.Z.A.); El is not very important for platelet function, at least in mice30; Paso Community College, El Paso, TX (D.L.). (2) Arhgef10 regulates platelet activation in vitro (eg, aggre- *Ms Qasim and Dr Karim contributed equally to this work. gation) and in vivo (eg, hemostasis)31; and (3) Arhegf12 is Correspondence to: Fatima Z. Alshbool, PharmD, PhD, Pharmaceutical “ ” 32 Sciences, School of Pharmacy, The University of Texas at El Paso, TX 79968. essential for normal platelet function. While Arhgef1 is E-mail: [email protected] another member of this family that is highly expressed in 26 Received December 6, 2018; accepted March 25, 2019. platelets, virtually nothing is known regarding its direct role ª 2019 The Authors. Published on behalf of the American Heart Association, in platelet function. Given that RhoA is a crucial regulator of Inc., by Wiley. This is an open access article under the terms of the Creative platelet responses mainly activated downstream of G12/13 Commons Attribution-NonCommercial License, which permits use, distribu- 33 tion and reproduction in any medium, provided the original work is properly and Gq coupled receptors, that these G-proteins are known 34,35 cited and is not used for commercial purposes. to play a vital role in platelet function, and that Arhgef1 DOI: 10.1161/JAHA.118.011712 Journal of the American Heart Association 1 Arhgef1 Regulates Platelet Function Qasim et al ORIGINAL RESEARCH Methods Clinical Perspective All experiments involving animals were performed in compli- What Is New? ance with the institutional guidelines and were approved by The University of Texas at El Paso Institutional Animal Care • This is the first study to demonstrate that Arhgef1 regulates platelet function, as well as hemostasis and thrombogen- and Use Committee. esis, in mice. The authors declare that all supporting data are available within the article data. Requests for detailed analytic What Are the Clinical Implications? methods will be addressed by the corresponding author. For requests for the Arhgef1 deletion mice, these will be • Arhgef1 represents a potential therapeutic target for referred by the corresponding author to the Mary Lyon managing thrombotic disorders. Centre at MRC Harwell (www.har.mrc.ac.uk), Oxfordshire, United Kingdom, and handled as per our Material Transfer 36 activates G13, we sought to examine the role of Arhgef1 in Agreement. platelet function in vitro and in vivo. Immunoblotting Materials and Methods Immunoblotting was performed as previously described.37,38 Briefly, and to confirm Arhgef1 deletion and that its deletion Reagents and Materials did not impact the expression levels of b3 and G13, platelet Thrombin, collagen, stir bars, and other disposables were from proteins were separated by SDS-PAGE and transferred to Chrono-Log Corporation, whereas U46619 was purchased Immobilon-P PVDF membranes (Millipore Corp). They were from Abcam. Fluorescein isothiocyanate–conjugated anti–P- then probed with anti-Arhgef1, anti-b3, anti-G13, or anti-actin selectin, anti-Arhgef1, anti-actin, anti-RhoA, anti-pROCK, and primary antibodies and visualized with an appropriate alkaline anti-Rap1b antibodies were purchased from Cell Signaling phosphatase–coupled secondary antibody using enhanced fl – Technology, Inc, whereas the anti-b3 and anti-G13 antibodies chemi uorescent substrate (GE Healthcare). For the RhoA were from Sigma Aldrich. The JON/A antibody was from Rho-associated kinase (ROCK) axis, washed platelets (Arhge- À À Emfret analytics. Fibrinogen was purchased from Sigma f1 / and WT) were stimulated with thrombin (0.1 U/mL) for Aldrich. The RhoA and Rap1b Activation Assay Biochem Kits 3 minutes, and processed as described above. Membranes were from Cytoskeleton Inc. Other reagents were of analytical were then probed with anti-RhoA, anti-pROCKIISer1366, and grade. anti-actin antibodies, and visualized with an appropriate horseradish peroxidase–coupled secondary antibody using enhanced chemiluminescence substrate (Thermo Scientific). Animals and Genotyping Images were obtained with ChemiDoc MP Imaging System (Bio-Rad). Arhgef1À/À mice were obtained from the Mary Lyon Centre at MRC Harwell (www.har.mrc.ac.uk), Oxfordshire, United Kingdom, and genotyped using a polymerase chain reac- tion (PCR)–based method. PCR was performed using the Tail Bleeding Time Assay following primers: Arhgef1-F (CCTTTGGGCTCTGACCTCTG), The tail bleeding time assay was performed as previously Arhgef1-R (AAGCCGTCAGTCCTCTGTCC), and CAS1 (TCGTGG- described.39–41 Briefly, mice were anesthetized and placed TATCGTTATGCGCC) with the following PCR condition: denat- on a homeothermic blanket (37°C) before the tail was uration: 94°C for 7 minutes, amplification: 94°C for 1 minute, transected 5 mm from the tip using a sterile scalpel. After 58°C for 1 minute, 72°C for 90 seconds for 34 cycles, and transection, the tail was immediately immersed in saline finally extension at 72°C for 10 minutes. After completion of (37°C constant temperature), and the time to bleeding the PCR cycle, amplified DNA samples were run in 2% agarose cessation was measured. Bleeding stoppage was not con- gel and visualized in the gel documentation system. The sidered complete until bleeding had stopped for 1 minute. expected products per genotype are as follows: wild-type For statistical analysis purposes, if bleeding did not stop in (WT): 520 bp, Het: 362/520 bp, and mutant: 362 bp. 10 minutes, the experiment was halted to limit blood loss Mice were housed in groups of 1 to 5 at 24°C, under 12/ from the mice and 10 minutes was considered the cutoff 12 light/dark cycles, with access to water and food bleeding time. The number of WT and knockout (KO) mice ad libitum. used was 8 each. DOI: 10.1161/JAHA.118.011712 Journal of the American Heart Association 2 Arhgef1 Regulates Platelet Function Qasim et al ORIGINAL RESEARCH In Vivo Ferric Chloride Carotid Artery using the HEMAVET 950FS Multispecies Hematology System Injury–Induced Thrombosis Model and adjusted to the indicated concentrations. This assay
Load more

Recommended publications
  • G Protein Alpha 13 (GNA13) (NM 006572) Human Tagged ORF Clone Lentiviral Particle Product Data
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for RC207762L3V G protein alpha 13 (GNA13) (NM_006572) Human Tagged ORF Clone Lentiviral Particle Product data: Product Type: Lentiviral Particles Product Name: G protein alpha 13 (GNA13) (NM_006572) Human Tagged ORF Clone Lentiviral Particle Symbol: GNA13 Synonyms: G13 Vector: pLenti-C-Myc-DDK-P2A-Puro (PS100092) ACCN: NM_006572 ORF Size: 1131 bp ORF Nucleotide The ORF insert of this clone is exactly the same as(RC207762). Sequence: OTI Disclaimer: The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info OTI Annotation: This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. RefSeq: NM_006572.3 RefSeq Size: 4744 bp RefSeq ORF: 1134 bp Locus ID: 10672 UniProt ID: Q14344, A0A024R8M0 Domains: G-alpha Protein Families: Druggable Genome Protein Pathways: Long-term depression, Regulation of actin cytoskeleton, Vascular smooth muscle contraction MW: 44 kDa This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 2 G protein alpha 13 (GNA13) (NM_006572) Human Tagged ORF Clone Lentiviral Particle – RC207762L3V Gene Summary: Guanine nucleotide-binding proteins (G proteins) are involved as modulators or transducers in various transmembrane signaling systems (PubMed:15240885, PubMed:16787920, PubMed:16705036, PubMed:27084452).
    [Show full text]
  • PLXNB1 (Plexin
    Atlas of Genetics and Cytogenetics in Oncology and Haematology OPEN ACCESS JOURNAL AT INIST-CNRS Gene Section Mini Review PLXNB1 (plexin B1) José Javier Gómez-Román, Montserrat Nicolas Martínez, Servando Lazuén Fernández, José Fernando Val-Bernal Department of Anatomical Pathology, Marques de Valdecilla University Hospital, Medical Faculty, University of Cantabria, Santander, Spain (JJGR, MN, SL, JFVB) Published in Atlas Database: March 2009 Online updated version: http://AtlasGeneticsOncology.org/Genes/PLXNB1ID43413ch3p21.html DOI: 10.4267/2042/44702 This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence. © 2010 Atlas of Genetics and Cytogenetics in Oncology and Haematology Identity Pseudogene No. Other names: KIAA0407; MGC149167; OTTHUMP00000164806; PLEXIN-B1; PLXN5; SEP Protein HGNC (Hugo): PLXNB1 Location: 3p21.31 Description Local order: The Plexin B1 gene is located between 2135 Amino acids (AA). Plexins are receptors for axon FBXW12 and CCDC51 genes. molecular guidance molecules semaphorins. Plexin signalling is important in pathfinding and patterning of both neurons and developing blood vessels. Plexin-B1 is a surface cell receptor. When it binds to its ligand SEMA4D it activates several pathways by binding of cytoplasmic ligands, like RHOA activation and subsequent changes of the actin cytoskeleton, axon guidance, invasive growth and cell migration. It monomers and heterodimers with PLXNB2 after proteolytic processing. Binds RAC1 that has been activated by GTP binding. It binds PLXNA1 and by similarity ARHGEF11, Note ARHGEF12, ERBB2, MET, MST1R, RND1, NRP1 Size: 26,200 bases. and NRP2. Orientation: minus strand. This family features the C-terminal regions of various plexins. The cytoplasmic region, which has been called DNA/RNA a SEX domain in some members of this family is involved in downstream signalling pathways, by Description interaction with proteins such as Rac1, RhoD, Rnd1 and other plexins.
    [Show full text]
  • The Smooth Muscle-Selective Rhogap GRAF3 Is a Critical Regulator of Vascular Tone and Hypertension
    ARTICLE Received 9 Jun 2013 | Accepted 11 Nov 2013 | Published 13 Dec 2013 DOI: 10.1038/ncomms3910 The smooth muscle-selective RhoGAP GRAF3 is a critical regulator of vascular tone and hypertension Xue Bai1, Kaitlin C. Lenhart1, Kim E. Bird1, Alisa A. Suen1, Mauricio Rojas2, Masao Kakoki1, Feng Li1, Oliver Smithies1,2, Christopher P. Mack1,2 & Joan M. Taylor1,2 Although hypertension is a worldwide health issue, an incomplete understanding of its aetiology has hindered our ability to treat this complex disease. Here we identify arhgap42 (also known as GRAF3) as a Rho-specific GAP expressed specifically in smooth muscle cells (SMCs) in mice and humans. We show that GRAF3-deficient mice exhibit significant hypertension and increased pressor responses to angiotensin II and endothelin-1; these effects are prevented by treatment with the Rho-kinase inhibitor, Y27632. RhoA activity and myosin light chain phosphorylation are elevated in GRAF3-depleted SMCs in vitro and in vivo, and isolated vessel segments from GRAF3-deficient mice show increased contractility. Taken together, our data indicate that GRAF3-mediated inhibition of RhoA activity in vascular SMCs is necessary for maintaining normal blood pressure homoeostasis. Moreover, these findings provide a potential mechanism for a hypertensive locus recently identified within arhgap42 and provide a foundation for the future development of innovative hypertension therapies. 1 Department of Pathology and Lab Medicine, University of North Carolina, 501 Brinkhous-Bullitt Building CB 7525, Chapel Hill, North Carolina 27599, USA. 2 McAllister Heart Institute, University of North Carolina, Chapel Hill, North Carolina 27599, USA. Correspondence and requests for materials shouldbe addressed to J.M.T.
    [Show full text]
  • Cdc42 and Rac1 Activity Is Reduced in Human Pheochromocytoma and Correlates with FARP1 and ARHGEF1 Expression
    234 P Croisé et al. Rho-GTPase activity in human 23:4 281–293 Research pheochromocytoma Cdc42 and Rac1 activity is reduced in human pheochromocytoma and correlates with FARP1 and ARHGEF1 expression Pauline Croisé1, Sébastien Houy1, Mathieu Gand1, Joël Lanoix2, Valérie Calco1, Petra Tóth1, Laurent Brunaud3, Sandra Lomazzi4, Eustache Paramithiotis2, Daniel Chelsky2, Stéphane Ory1,* and Stéphane Gasman1,* Correspondence 1Institut des Neurosciences Cellulaires et Intégratives (INCI), CNRS UPR 3212, Strasbourg, France should be addressed 2Caprion Proteome, Inc., Montréal, Québec, Canada to S Ory or S Gasman 3Service de Chirurgie Digestive, Hépato-bilaire et Endocrinienne, CHRU Nancy, Hôpitaux de Brabois, Email Vandoeuvre les Nancy, France [email protected] or 4Centre de Ressources Biologiques (CRB), CHRU Nancy, Hôpitaux de Brabois, Vandoeuvres les Nancy, France [email protected] *(S Ory and S Gasman contributed equally to this work) Abstract Among small GTPases from the Rho family, Cdc42, Rac, and Rho are well known to mediate Key Words a large variety of cellular processes linked with cancer biology through their ability to cycle f Rho-GTPases between an inactive (GDP-bound) and an active (GTP-bound) state. Guanine nucleotide f pheochromocytoma exchange factors (GEFs) stimulate the exchange of GDP for GTP to generate the activated f mass spectrometry form, whereas the GTPase-activating proteins (GAPs) catalyze GTP hydrolysis, leading to f Rho-GEF Endocrine-Related Cancer Endocrine-Related the inactivated form. Modulation of Rho GTPase activity following altered expression of Rho-GEFs and/or Rho-GAPs has already been reported in various human tumors. However, nothing is known about the Rho GTPase activity or the expression of their regulators in human pheochromocytomas, a neuroendocrine tumor (NET) arising from chromaffin cells of the adrenal medulla.
    [Show full text]
  • ARHGEF12 Regulates Erythropoiesis and Is Involved in Erythroid Regeneration After Ferrata Storti Foundation Chemotherapy in Acute Lymphoblastic Leukemia Patients
    Red Cell Biology & its Disorders ARTICLE ARHGEF12 regulates erythropoiesis and is involved in erythroid regeneration after Ferrata Storti Foundation chemotherapy in acute lymphoblastic leukemia patients Yangyang Xie,1* Li Gao,2* Chunhui Xu,3 Liming Chu,3,7 Lei Gao,4 Ruichi Wu,1 Yu Liu,1 Ting Liu,1 Xiao-jian Sun,5 Ruibao Ren,5 Jingyan Tang,1 Yi Zheng,6 Yong Zhou7 and Shuhong Shen1 1Key Lab of Pediatrics Hematology/Oncology, Ministry of Health, Department of Haematologica 2020 Hematology/Oncology, Shanghai Children's Medical Center, Shanghai Jiao Tong University, Volume 105(4):925-936 Shanghai, China; 2Department of Hematology and Oncology, Children's Hospital of Soochow University, Suzhou, China; 3Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China; 4CAS Key Laboratory of Genome Sciences and Information, Beijing Institute of Genomics, Beijing, China; 5State Key Laboratory for Medical Genomics, Shanghai Institute of Hematology, Ruijin Hospital, Shanghai, China; 6Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Research Foundation, Cincinnati, OH, USA and 7CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China *YX and LG contributed equally to this work. ABSTRACT ematopoiesis is a finely regulated process in vertebrates under both homeostatic and stress conditions. By whole exome sequencing, we Correspondence: Hstudied the genomics of acute lymphoblastic leukemia (ALL) YI ZHENG patients who needed multiple red blood cell (RBC) transfusions after inten- [email protected] sive chemotherapy treatment. ARHGEF12, encoding a RhoA guanine YONG ZHOU nucleotide exchange factor, was found to be associated with chemothera- [email protected] py-induced anemia by genome-wide association study analyses.
    [Show full text]
  • G-Protein-Coupled Receptor Signaling and Polarized Actin Dynamics Drive
    RESEARCH ARTICLE elifesciences.org G-protein-coupled receptor signaling and polarized actin dynamics drive cell-in-cell invasion Vladimir Purvanov, Manuel Holst, Jameel Khan, Christian Baarlink, Robert Grosse* Institute of Pharmacology, University of Marburg, Marburg, Germany Abstract Homotypic or entotic cell-in-cell invasion is an integrin-independent process observed in carcinoma cells exposed during conditions of low adhesion such as in exudates of malignant disease. Although active cell-in-cell invasion depends on RhoA and actin, the precise mechanism as well as the underlying actin structures and assembly factors driving the process are unknown. Furthermore, whether specific cell surface receptors trigger entotic invasion in a signal-dependent fashion has not been investigated. In this study, we identify the G-protein-coupled LPA receptor 2 (LPAR2) as a signal transducer specifically required for the actively invading cell during entosis. We find that 12/13G and PDZ-RhoGEF are required for entotic invasion, which is driven by blebbing and a uropod-like actin structure at the rear of the invading cell. Finally, we provide evidence for an involvement of the RhoA-regulated formin Dia1 for entosis downstream of LPAR2. Thus, we delineate a signaling process that regulates actin dynamics during cell-in-cell invasion. DOI: 10.7554/eLife.02786.001 Introduction Entosis has been described as a specialized form of homotypic cell-in-cell invasion in which one cell actively crawls into another (Overholtzer et al., 2007). Frequently, this occurs between tumor cells such as breast, cervical, or colon carcinoma cells and can be triggered by matrix detachment (Overholtzer et al., 2007), suggesting that loss of integrin-mediated adhesion may promote cell-in-cell invasion.
    [Show full text]
  • High Throughput Strategies Aimed at Closing the GAP in Our Knowledge of Rho Gtpase Signaling
    cells Review High Throughput strategies Aimed at Closing the GAP in Our Knowledge of Rho GTPase Signaling Manel Dahmene 1, Laura Quirion 2 and Mélanie Laurin 1,3,* 1 Oncology Division, CHU de Québec–Université Laval Research Center, Québec, QC G1V 4G2, Canada; [email protected] 2 Montréal Clinical Research Institute (IRCM), Montréal, QC H2W 1R7, Canada; [email protected] 3 Université Laval Cancer Research Center, Québec, QC G1R 3S3, Canada * Correspondence: [email protected] Received: 21 May 2020; Accepted: 7 June 2020; Published: 9 June 2020 Abstract: Since their discovery, Rho GTPases have emerged as key regulators of cytoskeletal dynamics. In humans, there are 20 Rho GTPases and more than 150 regulators that belong to the RhoGEF, RhoGAP, and RhoGDI families. Throughout development, Rho GTPases choregraph a plethora of cellular processes essential for cellular migration, cell–cell junctions, and cell polarity assembly. Rho GTPases are also significant mediators of cancer cell invasion. Nevertheless, to date only a few molecules from these intricate signaling networks have been studied in depth, which has prevented appreciation for the full scope of Rho GTPases’ biological functions. Given the large complexity involved, system level studies are required to fully grasp the extent of their biological roles and regulation. Recently, several groups have tackled this challenge by using proteomic approaches to map the full repertoire of Rho GTPases and Rho regulators protein interactions. These studies have provided in-depth understanding of Rho regulators specificity and have contributed to expand Rho GTPases’ effector portfolio. Additionally, new roles for understudied family members were unraveled using high throughput screening strategies using cell culture models and mouse embryos.
    [Show full text]
  • 4 Understanding the Role of GNA13 Deregulation in Lymphomagenesis
    Integrative Genomics Reveals a Role for GNA13 in Lymphomagenesis by Adrienne Greenough University Program in Genetics and Genomics Duke University Approved: ___________________________ Sandeep Dave, Supervisor ___________________________ Fred Dietrich ___________________________ Jack Keene ___________________________ Yuan Zhuang Dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the University Program in Genetics and Genomics in the Graduate School of Duke University 2014 i v ABSTRACT Integrative Genomics Reveals a Role for GNA13 in Lymphomagenesis by Adrienne Greenough University Program in Genetics and Genomics Duke University Approved: ___________________________ Sandeep Dave, Supervisor ___________________________ Fred Dietrich ___________________________ Jack Keene ___________________________ Yuan Zhuang An abstract of a dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the University Program in Genetics and Genomics in the Graduate School of Duke University 2014 Copyright by Adrienne Greenough 2014 Abstract Lymphomas comprise a diverse group of malignancies derived from immune cells. High throughput sequencing has recently emerged as a powerful and versatile method for analysis of the cancer genome and transcriptome. As these data continue to emerge, the crucial work lies in sorting through the wealth of information to hone in on the critical aspects that will give us a better understanding of biology and new insight for how to treat disease. Finding the important signals within these large data sets is one of the major challenges of next generation sequencing. In this dissertation, I have developed several complementary strategies to describe the genetic underpinnings of lymphomas. I begin with developing a better method for RNA sequencing that enables strand-specific total RNA sequencing and alternative splicing profiling in the same analysis.
    [Show full text]
  • Gene Networks Activated by Specific Patterns of Action Potentials in Dorsal Root Ganglia Neurons Received: 10 August 2016 Philip R
    www.nature.com/scientificreports OPEN Gene networks activated by specific patterns of action potentials in dorsal root ganglia neurons Received: 10 August 2016 Philip R. Lee1,*, Jonathan E. Cohen1,*, Dumitru A. Iacobas2,3, Sanda Iacobas2 & Accepted: 23 January 2017 R. Douglas Fields1 Published: 03 March 2017 Gene regulatory networks underlie the long-term changes in cell specification, growth of synaptic connections, and adaptation that occur throughout neonatal and postnatal life. Here we show that the transcriptional response in neurons is exquisitely sensitive to the temporal nature of action potential firing patterns. Neurons were electrically stimulated with the same number of action potentials, but with different inter-burst intervals. We found that these subtle alterations in the timing of action potential firing differentially regulates hundreds of genes, across many functional categories, through the activation or repression of distinct transcriptional networks. Our results demonstrate that the transcriptional response in neurons to environmental stimuli, coded in the pattern of action potential firing, can be very sensitive to the temporal nature of action potential delivery rather than the intensity of stimulation or the total number of action potentials delivered. These data identify temporal kinetics of action potential firing as critical components regulating intracellular signalling pathways and gene expression in neurons to extracellular cues during early development and throughout life. Adaptation in the nervous system in response to external stimuli requires synthesis of new gene products in order to elicit long lasting changes in processes such as development, response to injury, learning, and memory1. Information in the environment is coded in the pattern of action-potential firing, therefore gene transcription must be regulated by the pattern of neuronal firing.
    [Show full text]
  • Leukocyte Rhoa Exchange Factor Arhgef1 Mediates Vascular
    Leukocyte RhoA exchange factor Arhgef1 mediates vascular inflammation and atherosclerosis Maria Luigia Carbone, Gilliane Chadeuf, Sandrine Heurtebise-Chrétien, Xavier Prieur, Thibault Quillard, Yann Goueffic, Nathalie Vaillant, Marc Rio, Laure Castan, Maxim Durand, et al. To cite this version: Maria Luigia Carbone, Gilliane Chadeuf, Sandrine Heurtebise-Chrétien, Xavier Prieur, Thibault Quil- lard, et al.. Leukocyte RhoA exchange factor Arhgef1 mediates vascular inflammation and atheroscle- rosis. Journal of Clinical Investigation, American Society for Clinical Investigation, 2017, Equipe III Equipe IV, 127 (12), pp.4516–4526. 10.1172/JCI92702. hal-01832942 HAL Id: hal-01832942 https://hal.archives-ouvertes.fr/hal-01832942 Submitted on 11 Jul 2018 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. RESEARCH ARTICLE The Journal of Clinical Investigation Leukocyte RhoA exchange factor Arhgef1 mediates vascular inflammation and atherosclerosis Maria Luigia Carbone,1 Gilliane Chadeuf,1 Sandrine Heurtebise-Chrétien,1 Xavier Prieur,1 Thibault Quillard,2 Yann Goueffic,2,3 Nathalie Vaillant,1 Marc Rio,1 Laure Castan,1 Maxim Durand,4 Céline Baron-Menguy,1 Julien Aureille,1 Juliette Desfrançois,5 Angela Tesse,1 Raul M. Torres,6 and Gervaise Loirand1,3 1INSERM, CNRS, UNIV Nantes, l’institut du thorax, Nantes, France.
    [Show full text]
  • G-Protein-Coupled Receptor Signaling and Polarized Actin Dynamics 2 Drive Cell-In-Cell Invasion
    1 G-protein-coupled receptor signaling and polarized actin dynamics 2 drive cell-in-cell invasion 3 Vladimir Purvanov , Manuel Holst, Jameel Khan, Christian Baarlink and Robert Grosse 4 Institute of Pharmacology, University of Marburg, 35043, Marburg, Germany 5 Correspondence: [email protected] 6 7 8 Homotypic or entotic cell-in-cell invasion is an integrin-independent process 9 observed in carcinoma cells exposed during conditions of low adhesion such as in 10 exudates of malignant disease. Although active cell-in-cell invasion depends on 11 RhoA and actin the precise mechanism as well as the underlying actin structures 12 and assembly factors driving the process are unknown. Furthermore, whether 13 specific cell surface receptors trigger entotic invasion in a signal-dependent fashion 14 has not been investigated. Here we identify the G-protein-coupled LPA receptor 2 15 (LPAR2) as a signal transducer specifically required for the actively invading cell 16 during entosis. We find that G12/13 and PDZ-RhoGEF are required for entotic 17 invasion, which is driven by blebbing and a uropod-like actin structure at the rear 18 of the invading cell. Finally, we provide evidence for an involvement of the RhoA- 19 regulated formin Dia1 for entosis downstream of LPAR2. Thus, we delineate a 20 signaling process that regulates actin dynamics during cell-in-cell invasion. 21 1 22 Entosis has been described as a specialized form of homotypic cell-in-cell invasion in 23 which one cell actively crawls into another (Overholtzer, Mailleux et al. 2007). 24 Frequently, this occurs between tumor cells such as breast, cervical or colon 25 carcinoma cells and can be triggered by matrix detachment (Overholtzer, Mailleux et 26 al.
    [Show full text]
  • Arg1467his of ARHGEF11 Gene Is Associated with Insulin Resistance
    Diabetes In Press, published online February 7, 2007 Variants in ARHGEF11, a Candidate Gene for the Linkage to Type 2 Diabetes Mellitus on Chromosome 1q, Are Nominally Associated With Insulin Resistance and Type 2 Diabetes Mellitus in Pima Indians Received for publication 9 May 2006 and accepted in revised form 22 January 2007. Lijun Ma1, Robert L. Hanson1, Lorem N. Que1, Anna M. G. Cali1, Mao Fu2, Janel L. Mack1, Aniello M. Infante1, Sayuko Kobes1, Clifton Bogardus1, Alan R. Shuldiner2, and Leslie J. Baier1 Running Title: ARHGEF11 Variation and Type 2 Diabetes in Pima Indians 1Diabetes Molecular Genetics Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, DHHS, Phoenix, AZ 85004 2Division of Endocrinology, Diabetes and Nutrition, University of Maryland School of Medicine, Baltimore, MD 21201 Address Correspondence to: Leslie J. Baier, PhD Diabetes Molecular Genetics Section Phoenix Epidemiology and Clinical Research Branch National Institute of Diabetes, Digestive and Kidney Diseases National Institutes of Health 445 N. Fifth Street, Suite 210 Phoenix, AZ 85004 E-mail: [email protected] Additional information for this article can be found in an online appendix at http://dx.doi.org/10.2337/db07-0640. Copyright American Diabetes Association, Inc., 2007 Abstract A prior genome-wide linkage scan in Pima Indians indicated a young-onset (age<45 years) type 2 diabetes mellitus (T2DM) susceptibility locus on chromosome 1q21-q23. ARHGEF11, which encodes the Rho guanine nucleotide exchange factor 11, was analyzed as a positional candidate gene for this linkage because this protein may stimulate Rho-dependent signals, such as the insulin signaling cascade.
    [Show full text]